Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | KCNN4 | O15554 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | CES1 | P23141 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.38 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.38 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.38 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.38 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.38 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.38 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.38 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.38 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.38 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pyridine SCHEMBL8673561 | 0.89 | CYP1A2 (0.39) | CYP1A2CYP2D6KCNN4CYP2C19HIF1A | |
| SCHEMBL11061722 | 0.86 | KCNN4 (0.42) | CYP1A2CYP2D6KCNN4CYP2C19HIF1A | |
| SCHEMBL10693506 | 0.84 | MAPT (0.52) | CYP1A2CYP2D6KCNN4CYP2C19HIF1A | |
| SCHEMBL5071053 | 0.82 | KCNN4 (0.44) | CYP1A2CYP2D6KCNN4CYP2C19HIF1A | |
| SCHEMBL8894764 | 0.82 | CYP2C19 (0.47) | CYP1A2CYP2D6KCNN4CYP2C19HIF1A | |
| SCHEMBL5322361 | 0.82 | CYP2C19 (0.47) | CYP1A2CYP2D6KCNN4CYP2C19HIF1A | |
| SCHEMBL27264493 | 0.81 | KCNN4 (0.39) | CYP1A2CYP2D6KCNN4CYP2C19HIF1A | |
| SCHEMBL9876860 | 0.79 | CES1 (0.48) | CYP1A2CYP2D6KCNN4CYP2C19HIF1A | |
| SCHEMBL340836 | 0.78 | KCNN4 (0.52) | CYP1A2CYP2D6KCNN4CYP2C19HIF1A | |
| SCHEMBL5666953 | 0.78 | KCNN4 (0.47) | CYP1A2CYP2D6KCNN4CYP2C19HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7452545-B2 | Oligosaccharide aldonic acids and their topical use | YU RUEY J | 2008-11-18 | — | — | US | claimed |
| US-20080090772-A1 | Oligosaccharide Aldonic Acids and Their Topical Use | YU RUEY J | 2008-04-17 | — | — | US | claimed |
| EP-1685843-A1 | Oligosaccharide aldonic acids and their topical use | Yu, Ruey J., Dr. (US) | 2006-08-02 | — | — | EP | claimed |
| EP-1227820-B1 | OLIGOSACCHARIDE ALDONIC ACIDS AND THEIR TOPICAL USE | YU RUEY J (US) | 2006-04-19 | — | — | EP | claimed |
| US-20050171194-A1 | Enlargement of mucocutaneous or cutaneous organs and sites with topical compositions | YU RUEY J (US) | 2005-08-04 | — | — | US | claimed |
| WO-2005055947-A2 | ENLARGEMENT OF MUCOCUTANEOUS OR CUTANEOUS ORGANS AND SITES WITH TOPICAL COMPOSITIONS | YU RUEY J (US) | 2005-06-23 | — | — | WO | claimed |
| US-20040180854-A1 | Oligosaccharide aldonic acids and their topical use | YU RUEY J (US) | 2004-09-16 | — | — | US | claimed |
| US-6740327-B2 | USE FOR COSMETIC AND DERMATOLOGICAL INDICATIONS, REDUCING AND SOOTHING MUCOSA AND SKIN ERYTHEMA, INFLAMMATION OR REACTION CAUSED BY INTERNAL OR EXTERNAL FACTORS, WOUND HEALING, ETC. | YU RUEY J (US) | 2004-05-25 | — | — | US | claimed |
| EP-1227820-A2 | OLIGOSACCHARIDE ALDONIC ACIDS AND THEIR TOPICAL USE | Yu, Ruey J., Dr. (US) | 2002-08-07 | — | — | EP | claimed |
| US-20020028227-A1 | Oligosaccharide aldonic acids and their topical use | YU RUEY J (US) | 2002-03-07 | — | — | US | claimed |
| WO-2001001932-A2 | OLIGOSACCHARIDE ALDONIC ACIDS AND THEIR TOPICAL USE | YU RUEY J (US) | 2001-01-11 | — | — | WO | claimed |
| US-6054479-A | FOR FOOD, COSMETICS, DRUGS; ADDING ARYL ACETOXYACETIC ACID | TRISTRATA, INC. (A DELAWARE CORPORATION) (US) | 2000-04-25 | — | — | US | claimed |
| US-6046238-A | TOPICALLY APPLYING TO AN AFFECTED AREA OF SKIN AN EFFECTIVE AMOUNT OF ARYL 2-ACETOXYETHANOIC ACID, EFFECTIVE TO REMOVE OR PREVENT THE SPREAD OF ACNE VULGARIS | TRISTRATA, INC. (US) | 2000-04-04 | — | — | US | claimed |
| US-5958975-A | REVERSING OR PREVENTING TACHYPHYLAXIS OF PSORIASIS TO A CORTICOSTEROID; APPLYING TO PSORIATIC SKIN A CORTICOSTEROID AND AN ARYL 2-ACETOXY-ETHANOIC ACID; COSMETICS; FOODS | TRISTRATA, INC. (US) | 1999-09-28 | — | — | US | claimed |
| US-5874071-A | USING AN ARYL 2-ACETOXYETHANOIC ACID; DEODERANTS; ANTIPRESPIRANTS; PREVENTION OF ODORS ASSOCIATED WITH FOOT, SCALP, SKIN, NAILS AND FOLLICULR INFECTIONS; PROPIONIBACTERIUM ACNES; FOODS; COSMETICS; DRUGS | TRISTRATA, INC. (US) | 1999-02-23 | — | — | US | claimed |
| US-5807890-A | USING ARYL 2-ACETOXYETHANOIC ACID | TRISTRATA, INC. (US) | 1998-09-15 | — | — | US | claimed |
| EP-0789553-A4 | ANTIODOR, ANTIMICROBIAL AND PRESERVATIVE COMPOSITIONS AND METHODS OF USING SAME | TRISTRATA INC (US) | 1998-05-06 | — | — | EP | claimed |
| EP-0789553-A1 | ANTIODOR, ANTIMICROBIAL AND PRESERVATIVE COMPOSITIONS AND METHODS OF USING SAME | Tristrata, Inc. (US) | 1997-08-20 | — | — | EP | claimed |
| US-5641475-A | INCLUDES ARYL 2-ACETOXYETHANOIC ACID AS SYNERGIST OR AMPLIFIER | TRISTRATA, INC. (US) | 1997-06-24 | — | — | US | claimed |
| WO-1996013247-A1 | ANTIODOR, ANTIMICROBIAL AND PRESERVATIVE COMPOSITIONS AND METHODS OF USING SAME | TRISTRATA, INC. (US) | 1996-05-09 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080090772-A1 | Oligosaccharide Aldonic Acids and Their Topical Use | GLA, ALDOA, MAN2A1 | CYP1A2 2524/4885CYP2D6 2918/4885KCNN4 3806/4885 |
| US-20020028227-A1 | Oligosaccharide aldonic acids and their topical use | GLA, ALDOA, MAN2A1 | CYP1A2 2524/4885CYP2D6 2918/4885KCNN4 3806/4885 |
| US-20040180854-A1 | Oligosaccharide aldonic acids and their topical use | GLA, ALDOA, MAN2A1 | CYP1A2 2524/4885CYP2D6 2918/4885KCNN4 3806/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.